Antimicrobial Use and Resistance Among Gram-negative Bacilli in an Italian Intensive Care Unit (ICU)

References

• Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995; 274: 639–44.
   Google Scholar
• Vague J, Rossello J, Trilla A et al. Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE project, 1990 to 1994). Infect Control Hosp Epidemiol 1996; 17: 293 —7.
   Google Scholar
• Gould I. M. Risk factors for acquisition of multiply drug-resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13: Suppl. 1, 30-8.
   Google Scholar
• Paramythiotou E, Lucet JC, Timsit JF et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004; 38 (5): 670-7.
   Google Scholar
• D'Agata EM, Venkataraman L, DeGirolami P et al. Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a non-out-break period: prevalence, risk factors, and rate of infection. Crit Care Med. 1999; 27 (6): 1090–5.
   Google Scholar
• Flaherty JP, Weinstein R. A. Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 1996; 17: 236 —4.
   Web of Science ®Google Scholar
• Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994; 170 (6): 1622–5.
   Google Scholar
• Liu PY, Lau YJ, Hu BS et al. Comparison of susceptibil-ity to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from inten-sive care units. Diagn Microbiol Infect Dis. 1995; 22 (3): 285–91.
   Google Scholar
• Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance pro-gram. Clin Infect Dis 1996; 23 (4): 779–84.
   PubMed Web of Science ®Google Scholar
• Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluo-roquinolone use. JAMA. 2003; 289 (7): 885–8.
   PubMed Web of Science ®Google Scholar
• Barsic B, Beus I, Marton E, et al. Antibiotic resistance among Gram-negative nosocomial pathogens in the intensive care unit: results of 6-year body-site monitoring. Clin Ther. 1997; 19 (4): 691–700.
   PubMed Web of Science ®Google Scholar
• Archibald L, Phillips L, Monnet D, McGowan JE Jr,Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24 (2): 211–5.
   Google Scholar
• Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004; 48 (7): 2431–6.
   PubMed Web of Science ®Google Scholar
• Pieboji JG, Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon. Int J Infect Dis 2004; 8 (3): 147–54.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lac-tamases: a clinical update. Clin Microbiol Rev. 2005; 18 (4): 657–86.
   PubMed Web of Science ®Google Scholar
• Kim J, Kwon Y, Pai H, Kim JW, Cho DT. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998; 36: 1446-1449.
   Google Scholar
• Livermore DM, Brown DF. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 2001; 48 (Suppl 51): 59–64.
   PubMedGoogle Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16 (3): 128–40.
   PubMed Web of Science ®Google Scholar
• Jorgensen JH, Turnidge JD, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods, In PR Murray, EJ Baron, MA Pfaller, FC Tenover, and RH Yolken (ed.), Manual of clinical microbiology. 7th ed. American Society for Microbiology, Washington, D.C. 1999: 1526-1543.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7, 7th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa. 2000.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically; Approved standard. NCCLS docu-ment M100-513. National Committee for Clinical Laboratory Standards. Wayne, Pa. 2003.
   Google Scholar
• Steward CD, Rasheed JK, Hubert SK et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum g-lactamase detection methods. J Clin Microbiol 2001; 39: 2864–2872.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2003.
   Google Scholar
• Fleiss JL. Statistical methods for rates and proportions, 2nd edition. J Wiley & Sons, Inc. 1981: 143-6.
   Google Scholar
• Agresti A. An introduction to categorical data analysis. J Wiley & Sons, Inc. 1996.
   Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epi-demiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348 (16): 1546–54.
   PubMed Web of Science ®Google Scholar
• Gaynes R, Jonathan RE. Overview of nosocomial infec-tions caused by gram-negative bacilli. Clin Infect Dis 2005; 41: 848–854.
   PubMed Web of Science ®Google Scholar
• Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recov-ered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23 (1): 118–24.
   PubMed Web of Science ®Google Scholar
• Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of the antimicrobial ther-apy. Clin Infect Dis 2001; 32: 1085–1089.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Von Gottberg A et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004; 39: 31–7.
   Google Scholar
• DuBois SK, Marriott MS, Amyes SGB. TEM- and SHV-derived extended-spectrum g-lactamases: relationship between selection, structure and function. J Antimicrob Chemother 1995; 35: 7–22.
   PubMed Web of Science ®Google Scholar
• Sanders CC Cefepime: the next generation? Clin Infect Dis 1993; 17: 369–379.
   Google Scholar
• Paterson DL, Mulazimoglu L, Casellas JM et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473–8.
   Google Scholar
• Bradford PA. Extended-Spectrum-beta-Lactamases in the 21st Century: Characterization, epidemiology, and detec-tion of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–951.
   PubMed Web of Science ®Google Scholar
• Carretto E, Emmi V, Barbarini D et al. Extended-spec-trum beta-lactamase-producing Enterobacteriaceae in an Italian intensive care unit: clinical and therapeutical remarks. J Chemother 2004; 16 (2): 145-50.
   Google Scholar
• Giakkoupi P, Petrikkos G, Tzouvelekis LS, Tsonas S, Legakis NJ, Vatopoulos AC. Spread of integron-associated VIM-type metallo-g-lactamase genes among imipenem-nonsus-ceptible Pseudomonas aeruginosa strains in Greek hospitals. J Clin Microbiol 2003; 41: 822–825.
   PubMed Web of Science ®Google Scholar